Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
19.57
-0.24 (-1.21%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
6
Next >
Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
November 14, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Third-Quarter 2024 Results
October 30, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
October 26, 2024
IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders.
Via
Benzinga
Why Bausch + Lomb Rallied Today
September 16, 2024
The highly indebted healthcare stock rose on rumors it may be selling itself.
Via
The Motley Fool
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags
October 21, 2024
S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.
Via
Benzinga
Topics
Bankruptcy
Stocks
Exposures
Financial
Legal
US Equities
This Advance Auto Parts Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
October 15, 2024
Via
Benzinga
Why Bausch + Lomb Stock Soared by Over 7% on Monday
October 14, 2024
It was quite a busy and eventful day for the company.
Via
The Motley Fool
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
October 14, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
October 14, 2024
Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.
Via
Benzinga
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
October 14, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30
October 09, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 02, 2024
Via
Benzinga
Bausch + Lomb Launches Opal™ Digital Marketplace in the United States
October 01, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
September 25, 2024
The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.
Via
MarketBeat
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
September 18, 2024
Via
Benzinga
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
September 16, 2024
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
September 16, 2024
Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.
Via
Investor's Business Daily
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
September 16, 2024
Via
Benzinga
Bausch + Lomb Announces Second-Quarter 2024 Results
July 31, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
July 31, 2024
Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
July 11, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
July 31, 2024
Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
July 08, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
Why Is Clearside Biomedical Stock Gaining Today?
June 25, 2024
Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS...
Via
Benzinga
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
June 17, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
June 10, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
June 03, 2024
From
Bausch + Lomb Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.